Albuvirtide is a human immunodeficiency virus type 1 (HIV-1) fusion inhibitor indicated in combination with other antiretroviral agent(s) for treatment of HIV-1 infection in treatment-experienced patients with HIV-1 replication despite ongoing antiretroviral therapy.